Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Submitted by
admin
on January 11, 2016 - 11:55am
Source:
Forbes
News Tags:
Juno Therapeutics
AbVitro
M&A
immunotherapy
Headline:
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Do Not Allow Advertisers to Use My Personal information
